Health care resource use and costs by age category
| Variable . | Aged 65-69 y . | Aged 70-74 y . | Aged ≥75 y . | Total . | ||||
|---|---|---|---|---|---|---|---|---|
| (n = 168) . | (n = 143) . | (n = 134) . | (n = 445) . | |||||
| Total health care costs, $ | ||||||||
| Mean (SD)∗ | 311 699 | (189 161) | 296 192 | (196 115) | 271 767 | (190 975) | 294 692 | (192 232) |
| Median | 364 036 | 342 099 | 333 698 | 352 572 | ||||
| Service use | ||||||||
| Among patients receiving CAR T-cell therapy in an inpatient setting, n (%) | 144 | (85.7) | 125 | (87.4) | 97 | (72.4) | 366 | (82.2) |
| Rehospitalization† | ||||||||
| ≥1 visit, n (%) | 49 | (34.0) | 28 | (22.4) | 28 | (28.9) | 105 | (28.7) |
| Total visits, mean (SD) | 1.3 | (0.7) | 1.7 | (1) | 1.5 | (0.9) | 1.5 | (0.8) |
| Length of stay, mean (SD), d | 8.22 | (6.97) | 6.62 | (5.08) | 7.83 | (7.5) | 7.62 | (6.59) |
| ED services‡ | ||||||||
| ≥1 visit, n (%) | 47 | (32.6) | 37 | (29.6) | 27 | (27.8) | 111 | (30.3) |
| Total visits, mean (SD) | 1.6 | (0.9) | 1.7 | (0.9) | 1.7 | (0.9) | 1.6 | (0.9) |
| Outpatient services | ||||||||
| ≥1 visit, n (%) | 144 | (100.0) | 125 | (100.0) | 97 | (100.0) | 366 | (100.0) |
| Total visits, mean (SD) | 17.7 | (8.9) | 18 | (8.7) | 16.3 | (8.6) | 17.4 | (8.7) |
| Among patients receiving CAR T-cell therapy in an outpatient setting, n (%) | 24 | (14.3) | 18 | (12.6) | 37 | (27.6) | 79 | (17.8) |
| Follow-up inpatient services† | ||||||||
| ≥1 visit, n (%) | 13 | (54.2) | <11 | (∼)§ | 11 | (29.70) | 33 | (41.80) |
| Total visits, mean (SD) | 1.4 | (0.7) | 1.3 | (0.7) | 1.4 | (0.5) | 1.4 | (0.6) |
| Length of stay, mean (SD), d | 6.28 | (4.47) | 7.75 | (7) | 8.87 | (7.63) | 7.53 | (6.31) |
| ED services‡ | ||||||||
| ≥1 visit, n (%) | <11 | (∼)§ | <11 | (∼)§ | 11 | (29.70) | 25 | (31.60) |
| Total visits, mean (SD) | 1.8 | (0.9) | 2.3 | (1.9) | 1.9 | (0.9) | 1.9 | (1.1) |
| Outpatient services (not inclusive of initial CAR T-cell therapy visit) | ||||||||
| ≥1 visit, n (%) | 24 | (100.0) | 18 | (100.0) | 37 | (100.0) | 79 | (100.0) |
| Total visits, mean (SD) | 21.8 | (10.5) | 17.9 | (9.9) | 17.6 | (8.2) | 19 | (9.4) |
| Variable . | Aged 65-69 y . | Aged 70-74 y . | Aged ≥75 y . | Total . | ||||
|---|---|---|---|---|---|---|---|---|
| (n = 168) . | (n = 143) . | (n = 134) . | (n = 445) . | |||||
| Total health care costs, $ | ||||||||
| Mean (SD)∗ | 311 699 | (189 161) | 296 192 | (196 115) | 271 767 | (190 975) | 294 692 | (192 232) |
| Median | 364 036 | 342 099 | 333 698 | 352 572 | ||||
| Service use | ||||||||
| Among patients receiving CAR T-cell therapy in an inpatient setting, n (%) | 144 | (85.7) | 125 | (87.4) | 97 | (72.4) | 366 | (82.2) |
| Rehospitalization† | ||||||||
| ≥1 visit, n (%) | 49 | (34.0) | 28 | (22.4) | 28 | (28.9) | 105 | (28.7) |
| Total visits, mean (SD) | 1.3 | (0.7) | 1.7 | (1) | 1.5 | (0.9) | 1.5 | (0.8) |
| Length of stay, mean (SD), d | 8.22 | (6.97) | 6.62 | (5.08) | 7.83 | (7.5) | 7.62 | (6.59) |
| ED services‡ | ||||||||
| ≥1 visit, n (%) | 47 | (32.6) | 37 | (29.6) | 27 | (27.8) | 111 | (30.3) |
| Total visits, mean (SD) | 1.6 | (0.9) | 1.7 | (0.9) | 1.7 | (0.9) | 1.6 | (0.9) |
| Outpatient services | ||||||||
| ≥1 visit, n (%) | 144 | (100.0) | 125 | (100.0) | 97 | (100.0) | 366 | (100.0) |
| Total visits, mean (SD) | 17.7 | (8.9) | 18 | (8.7) | 16.3 | (8.6) | 17.4 | (8.7) |
| Among patients receiving CAR T-cell therapy in an outpatient setting, n (%) | 24 | (14.3) | 18 | (12.6) | 37 | (27.6) | 79 | (17.8) |
| Follow-up inpatient services† | ||||||||
| ≥1 visit, n (%) | 13 | (54.2) | <11 | (∼)§ | 11 | (29.70) | 33 | (41.80) |
| Total visits, mean (SD) | 1.4 | (0.7) | 1.3 | (0.7) | 1.4 | (0.5) | 1.4 | (0.6) |
| Length of stay, mean (SD), d | 6.28 | (4.47) | 7.75 | (7) | 8.87 | (7.63) | 7.53 | (6.31) |
| ED services‡ | ||||||||
| ≥1 visit, n (%) | <11 | (∼)§ | <11 | (∼)§ | 11 | (29.70) | 25 | (31.60) |
| Total visits, mean (SD) | 1.8 | (0.9) | 2.3 | (1.9) | 1.9 | (0.9) | 1.9 | (1.1) |
| Outpatient services (not inclusive of initial CAR T-cell therapy visit) | ||||||||
| ≥1 visit, n (%) | 24 | (100.0) | 18 | (100.0) | 37 | (100.0) | 79 | (100.0) |
| Total visits, mean (SD) | 21.8 | (10.5) | 17.9 | (9.9) | 17.6 | (8.2) | 19 | (9.4) |
∼, value withheld to comply with the CMS policy of minimizing the risk to identify patients.
Total Medicare payments on all accepted inpatient, outpatient, skilled nursing facility, home health agency, hospice, professional, and pharmacy Medicare FFS claims found within 90 days after CAR T-cell therapy, inclusive of CAR T-cell therapy.
Inpatient hospital discharges identified on inpatient institutional claims within 90 days after CAR T-cell therapy.
Includes both ED visits without hospital admission (treat and release) and ED visits that resulted in admission.
The Centers for Medicare & Medicaid Services (CMS) cell size suppression policy sets minimum thresholds for the display of CMS data, in which no cell (eg, admissions, discharges, patients, and services) containing a value of 1 to 10 can be reported directly.